
Company profile · Onderzoeks- & kennisinstelling
CE Delft SUSBIND
- Furniture
- Onderzoeks- & kennisinstelling
- Delft
- Furniture · Delft
- Employees
- 51–200
- Province
- Zuid-Holland
- Country
- Netherlands
About CE Delft SUSBIND
SUSBIND has received funding from the Bio Based Industries Joint Undertaking (JU) under grant agreement No 792063. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and the Bio Based Industries Consortium.
Summary of all SUSBIND analyses The SUSBIND project was completed in August 2022. Over the past years, the SUSBIND consortium partners have developed the ‘SUSBIND adhesive’. This adhesive is partly bio-based (80% biogenic carbon). It consists of biobased fructose and hydroxymethylfurfural (HMF) and fossil bis(hexamethylene)triamine (BHT). The SUSBIND adhesive has shown promising technical performance in boards produced at small scale and in a prototype final product (at Technology Readiness Level, TRL 5).
The results, conclusions and recommendations of CE Delft’s analyses are available at the website https://cedelft.eu/method/susbind/
SUSBIND – Consolidated LCA, techno-economic analysis and market uptake analysis Other publications SUSBIND – LCA of current state-of-the-art-resins SUSBIND – LCA of proposed feedstock SUSBIND – LCA of proposed resins SUSBIND – LCA of adhesive systems SUSBIND – Guideline for carbon footprint reduction at TRL9 SUSBIND – Market uptake analysis
Address
Headquarters
Oude Delft 1802611 DelftZuid-Holland, Netherlands
Similar companies
Companies with a similar profile, Zuid-Holland first.

Lignitec
Biotechnology · Delft
2–10 employeesView profile

Sustainable Adhesive Products
Packaging and Containers · Capelle aan den IJssel
2–10 employeesView profile

Dutch Mountain Solutions
Renewables & Environment · Rotterdam
2–10 employeesView profile
studioBIO
Marketing and Advertising · Rotterdam
0–1 employeesView profile

BUSIS GROUP
Architecture & Planning · Roelofarendsveen
51–200 employeesView profile

Bio4Products project
Biotechnology · Enschede
11–50 employeesView profile